細胞・遺伝子サプライチェーン・サービスの世界市場

細胞・遺伝子サプライチェーン・サービスの世界市場は2030年までに22億米ドルに達する

2024年に14億米ドルと推定される細胞・遺伝子サプライチェーン・サービスの世界市場は、2024年から2030年にかけてCAGR 7.5%で成長し、2030年には22億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるPresence On Cloud Technologyは、CAGR 6.1％を記録し、分析期間終了時には14億米ドルに達すると予測されます。プレゼンス・オン・プレミス技術」セグメントの成長率は、分析期間中CAGR 10.1％と推定されます。

米国市場は3億8,250万米ドルと推定、中国はCAGR 11.4％で成長予測

米国の細胞・遺伝子サプライチェーン・サービス市場は、2024年に3億8,250万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに4億5,140万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.8%と7.1%と予測されています。欧州では、ドイツがCAGR 4.9%で成長すると予測されています。

世界の細胞・遺伝子サプライチェーン・サービス市場- 主要動向と促進要因のまとめ

何が細胞・遺伝子治療ロジスティクスの革命を促進しているのか？

細胞・遺伝子治療（CGT）がニッチな実験的治療から主流の臨床応用へと移行するにつれ、細胞・遺伝子サプライチェーン・サービス市場はダイナミックな変貌を遂げつつあります。これらの治療法は、温度、時間、汚染に敏感であるため、高度に専門化されたロジスティクスが要求されます。承認された細胞・遺伝子治療の数が世界的に増加し続ける中、オーダーメイドのサプライチェーン・サービスの必要性が高まっています。これには、コールドチェーン・ロジスティクス、リアルタイムの追跡、凍結保存、製造拠点と治療センター間の安全でタイムリーな輸送などが含まれます。従来の医薬品ロジスティクス・インフラストラクチャーは、こうした複雑性を処理するのに適していないため、業界全体が専門プロバイダーへのシフトを促しています。

CGTの臨床試験、特に患者ごとに製造する必要がある自家療法の数が増加しているため、正確で統合されたサプライチェーンモデルの必要性が高まっています。このようなサービスは、製品の完全性を保証するだけでなく、プロセス全体を通じてCoCとCoCを維持しなければならないです。規制基準、時間帯管理、税関要件が重大なリスクをもたらしかねない国際共同治験では、物流の課題がさらに複雑になります。このため、サプライチェーンの俊敏性とコンプライアンスに関する専門知識が重視され、エンドツーエンドのソリューションを提供するベンダーへの需要が高まっています。

技術の進歩はサプライチェーンの情勢をどのように変えているか？

最先端のテクノロジーは、細胞治療や遺伝子治療の輸送、追跡、モニタリングの方法を再定義しつつあります。リアルタイムのGPSやIoT対応のモニタリング・システムは業界標準になりつつあり、温度、位置、その他の重要なパラメータの継続的な監視を可能にしています。このような進歩は、環境条件が必要な範囲から逸脱すると、劣化したり生存できなくなったりする可能性のある生体療法の完全性を維持するために不可欠です。自動化、ロボット工学、AIはまた、冷蔵保管環境における倉庫作業と予知保全を合理化し、人的エラーと運用の非効率性を減らしています。

さらに、安全な追跡のためのブロックチェーンの使用は、製品の旅の不変のデジタル台帳を確保し、人気を集めています。この技術革新は、特に欧州と北米において、トレーサビリティに対する規制上の要求へのコンプライアンスをサポートしています。もう一つの画期的な開発は、デジタル・ツインの出現です。これは、様々なシナリオの下でサプライチェーン・ロジスティクスをシミュレートし、結果を最適化し、混乱を未然に防ぐ仮想モデルです。これらのテクノロジーは、利害関係者に可視性の強化、リスクの軽減、救命治療のオンタイムデリバリーの改善を可能にし、テクノロジー主導型企業を市場の最前線に位置づけています。

なぜ戦略的提携と規制遵守が重要なのか？

CGTロジスティクスは複雑で利害関係が大きいため、バイオ製薬会社、ロジスティクス・プロバイダー、病院、規制当局など複数の利害関係者が緊密に協力する必要があります。治療の開発企業と専門的なロジスティクス企業とのパートナーシップは、業務の合理化、タイムラインの調整、厳格な品質基準の遵守を目的として、より頻繁に行われるようになってきています。製薬会社は、社内でゼロから機能を構築するのではなく、CGTの専門知識を持つ第三者ベンダーにロジスティクスをアウトソーシングするケースが増えています。このようなパートナーシップは、安定性を確保し、イノベーションへの投資を共有するため、長期的な提携として構成されることが多いです。

特に、温度管理、製品のトレーサビリティ、文書化に関するガイドラインが当局によって厳格化される中、規制コンプライアンスは依然として重要な焦点となっています。FDA、EMA、PMDAなどの機関は適正流通規範（GDP）規制を強化しており、完全遵守を証明できる企業は競争力を獲得しています。さらに、地域間の規制調和への取り組みは、国境を越えた輸送を簡素化し、遅延を減らし、新興市場へのアクセスを拡大しています。戦略的提携と強固なコンプライアンス・インフラの相乗効果は、このサプライチェーン分野特有の課題を乗り切る上で不可欠であることが証明されつつあります。

市場促進要因とは？

細胞・遺伝子サプライチェーン・サービス市場の成長は、いくつかの要因によって牽引されています。細胞治療や遺伝子治療の開発が急増しており、世界中で数百もの製品が臨床パイプラインにあるため、カスタマイズされた高信頼性のロジスティクスに対する需要が高まっています。バイオテクノロジーの進歩と個別化医療へのシフトは、正確で患者中心の輸送ソリューションの必要性を強調しています。また、生体治療薬の取り扱いが複雑化したことで、極低温保管、温度管理された包装、ラストマイル配送の能力拡大も必要となっています。さらに、規制当局の監視が強化され、デジタル・トレーサビリティ・システムの必要性が高まっていることから、技術的に対応可能でコンプライアンスに準拠したサプライチェーン・ネットワークへの投資が促されています。患者の期待の高まりとCGT臨床試験の世界化は、機敏で世界に調和したロジスティクス・プラットフォームの必要性をさらに高めています。これらの集約的な要因が市場を後押しし、ヘルスケアロジスティクスの中で最も急成長しているニッチの一つとなっています。

セグメント

技術（クラウド技術の存在,プレミス技術の存在）;エンド用途（バイオバンク/セルバンク最終用途,病院最終用途,研究機関最終用途,細胞治療ラボ最終用途,その他最終用途）;用途（オーダー＆スケジューリング用途,サンプル収集用途,ロジスティクス用途,治療後フォローアップ用途）

調査対象企業の例（注目の34社）

• Almac Group
• AmerisourceBergen Corporation
• Arvato Supply Chain Solutions
• Biocair
• BioLife Solutions
• Brooks Life Sciences
• Catalent, Inc.
• Charles River Laboratories
• Clarkston Consulting
• Cryoport
• Fujifilm Diosynth Biotechnologies
• Genedata
• Haemonetics
• Hypertrust Patient Data Care
• Lonza Group AG
• Marken（UPS Company）
• Miltenyi Biotec
• Thermo Fisher Scientific
• TrakCel
• World Courier

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Cell and Gene Supply Chain Services Market to Reach US$2.2 Billion by 2030

The global market for Cell and Gene Supply Chain Services estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Presence On Cloud Technology, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Presence ln-Premises Technology segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$382.5 Million While China is Forecast to Grow at 11.4% CAGR

The Cell and Gene Supply Chain Services market in the U.S. is estimated at US$382.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$451.4 Million by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Cell and Gene Supply Chain Services Market - Key Trends & Drivers Summarized

What’s Fueling the Revolution in Cell and Gene Therapy Logistics?

The cell and gene supply chain services market is undergoing a dynamic transformation as cell and gene therapies (CGTs) transition from niche experimental treatments to mainstream clinical applications. These therapies demand highly specialized logistics due to their sensitivity to temperature, time, and contamination. As the number of approved cell and gene therapies continues to rise globally, the need for tailored supply chain services is intensifying. This includes cold chain logistics, real-time tracking, cryopreservation, and secure, timely transportation between manufacturing sites and treatment centers. Traditional pharmaceutical logistics infrastructures are ill-suited to handle these complexities, prompting an industry-wide shift toward specialized providers.

The rising number of clinical trials for CGTs-especially autologous therapies that require patient-specific manufacturing-has heightened the need for precise, integrated supply chain models. These services must not only ensure product integrity but also maintain chain-of-identity and chain-of-custody throughout the process. The logistical challenges become even more intricate with international trials, where regulatory standards, time zone management, and customs requirements can introduce critical risks. This is creating a premium on supply chain agility and compliance expertise, fueling demand for vendors offering end-to-end solutions.

How Are Technological Advances Reshaping the Supply Chain Landscape?

Cutting-edge technologies are redefining how cell and gene therapies are transported, tracked, and monitored. Real-time GPS and IoT-enabled monitoring systems are becoming industry standards, allowing continuous surveillance of temperature, location, and other critical parameters. Such advancements are vital for maintaining the integrity of living therapies, which can degrade or become nonviable if environmental conditions deviate from their required ranges. Automation, robotics, and AI are also streamlining warehouse operations and predictive maintenance within cold storage environments, reducing human error and operational inefficiencies.

In addition, the use of blockchain for secure tracking is gaining traction, ensuring an immutable digital ledger of the product journey. This innovation supports compliance with regulatory demands for traceability, especially in Europe and North America. Another game-changing development is the emergence of digital twins-virtual models that simulate supply chain logistics under various scenarios to optimize outcomes and preempt disruptions. These technologies are empowering stakeholders to enhance visibility, mitigate risks, and improve on-time delivery of life-saving treatments, positioning tech-driven firms at the forefront of the market.

Why Are Strategic Collaborations and Regulatory Compliance Critical?

The intricate and high-stakes nature of CGT logistics necessitates close collaboration across multiple stakeholders, including biopharma companies, logistics providers, hospitals, and regulators. Partnerships between therapy developers and specialized logistics firms are becoming more frequent, aiming to streamline operations, align timelines, and meet strict quality standards. Pharmaceutical companies are increasingly outsourcing their logistics to third-party vendors with dedicated CGT expertise rather than building internal capabilities from scratch. These partnerships are often structured as long-term alliances to ensure stability and shared investment in innovation.

Regulatory compliance remains a critical focus, especially as authorities tighten guidelines around temperature control, product traceability, and documentation. Agencies such as the FDA, EMA, and PMDA are reinforcing Good Distribution Practice (GDP) regulations, and companies that can demonstrate full adherence are gaining a competitive edge. Moreover, regulatory harmonization efforts between regions are simplifying cross-border transport, reducing delays, and expanding access to emerging markets. The synergy of strategic alliances and robust compliance infrastructure is proving essential in navigating the unique challenges of this supply chain sector.

What Are the Core Drivers Behind Market Acceleration?

The growth in the cell and gene supply chain services market is driven by several factors. The surge in cell and gene therapy development, with hundreds of products in clinical pipelines globally, is increasing the demand for customized, high-integrity logistics. Advances in biotechnology and the shift toward personalized medicine are emphasizing the need for precise, patient-centric transport solutions. The complexity of handling living therapies is also necessitating expanded capabilities in cryogenic storage, temperature-controlled packaging, and last-mile delivery. Additionally, the rise in regulatory scrutiny and the need for digital traceability systems are prompting investments in tech-enabled, compliant supply chain networks. Evolving patient expectations and the globalization of CGT clinical trials are further fueling the requirement for agile, globally harmonized logistics platforms. These converging factors are collectively propelling the market forward, making it one of the fastest-growing niches within healthcare logistics.

SCOPE OF STUDY:

The report analyzes the Cell and Gene Supply Chain Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Presence On Cloud Technology, Presence ln-Premises Technology); End-Use (Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use, Other End-Uses); Application (Ordering & Scheduling Applications, Sample Collection Applications, Logistics Applications, Post Treatment Follow-Up Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Almac Group
• AmerisourceBergen Corporation
• Arvato Supply Chain Solutions
• Biocair
• BioLife Solutions
• Brooks Life Sciences
• Catalent, Inc.
• Charles River Laboratories
• Clarkston Consulting
• Cryoport
• Fujifilm Diosynth Biotechnologies
• Genedata
• Haemonetics
• Hypertrust Patient Data Care
• Lonza Group AG
• Marken (UPS Company)
• Miltenyi Biotec
• Thermo Fisher Scientific
• TrakCel
• World Courier

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Cell and Gene Supply Chain Services - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Biotechnological Advancements Propel Supply Chain Complexity
  • Personalized Medicine Trends Expand Logistics Requirements
  • Cold Chain Logistics Become Critical for Therapy Viability
  • Integration of Digital Platforms Enhances Supply Chain Transparency
  • Growth in Cell and Gene Therapies Increases Demand for Specialized Services
  • Investment in Infrastructure Supports Market Expansion
  • Automation and AI Integration Optimize Supply Chain Efficiency
  • Rising Demand for Regenerative Medicines Drives Service Needs
  • Risk Management Strategies Address Supply Chain Vulnerabilities
  • Development of Standardized Protocols Improves Operational Consistency
  • Sustainability Initiatives Influence Supply Chain Practices
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cell and Gene Supply Chain Services Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cell and Gene Supply Chain Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Cell and Gene Supply Chain Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Presence On Cloud Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Presence On Cloud Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Presence On Cloud Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Presence ln-Premises Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Presence ln-Premises Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Presence ln-Premises Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Logistics Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Logistics Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Logistics Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Post Treatment Follow-Up Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Post Treatment Follow-Up Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Post Treatment Follow-Up Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ordering & Scheduling Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ordering & Scheduling Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Ordering & Scheduling Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Sample Collection Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Sample Collection Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Sample Collection Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Biobank / Cell-Bank End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Biobank / Cell-Bank End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Biobank / Cell-Bank End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Cell Therapy Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Cell Therapy Labs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Cell Therapy Labs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Cell and Gene Supply Chain Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Cell and Gene Supply Chain Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Cell and Gene Supply Chain Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Cell and Gene Supply Chain Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Cell and Gene Supply Chain Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Cell and Gene Supply Chain Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Cell and Gene Supply Chain Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Cell and Gene Supply Chain Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Cell and Gene Supply Chain Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Cell and Gene Supply Chain Services by Technology - Presence On Cloud Technology and Presence ln-Premises Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Cell and Gene Supply Chain Services by Technology - Percentage Breakdown of Value Sales for Presence On Cloud Technology and Presence ln-Premises Technology for the Years 2014, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Cell and Gene Supply Chain Services by Application - Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Cell and Gene Supply Chain Services by Application - Percentage Breakdown of Value Sales for Logistics Applications, Post Treatment Follow-Up Application, Ordering & Scheduling Applications and Sample Collection Applications for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Cell and Gene Supply Chain Services by End-Use - Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Cell and Gene Supply Chain Services by End-Use - Percentage Breakdown of Value Sales for Biobank / Cell-Bank End-Use, Hospitals End-Use, Research Institutes End-Use, Cell Therapy Labs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION